Thermo Fisher Scientific Inc (NYSE: TMO) on Friday, soared 0.69% from the previous trading day, before settling in for the closing price of $475.03. Within the past 52 weeks, TMO’s price has moved between $385.46 and $627.88.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 12.52% over the last five years. The company achieved an average annual earnings per share of 2.93%. With a float of $376.86 million, this company’s outstanding shares have now reached $377.49 million.
The firm has a total of 125000 workers. Let’s measure their productivity. In terms of profitability, gross margin is 41.74%, operating margin of 17.14%, and the pretax margin is 16.3%.
Thermo Fisher Scientific Inc (TMO) Insider Activity
Observing investor behavior towards Diagnostics & Research industry stocks is more important than anything else. The insider ownership of Thermo Fisher Scientific Inc is 0.17%, while institutional ownership is 91.28%. The most recent insider transaction that took place on Jul 25 ’25, was worth 191,992. Before that another transaction happened on May 12 ’25, when Company’s Executive Vice President sold 400 for $411.11, making the entire transaction worth $164,444. This insider now owns 22,767 shares in total.
Thermo Fisher Scientific Inc (TMO) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 6.52 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 2.93% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.18% during the next five years compared to 12.52% growth over the previous five years of trading.
Thermo Fisher Scientific Inc (NYSE: TMO) Trading Performance Indicators
Thermo Fisher Scientific Inc (TMO) is currently performing well based on its current performance indicators. A quick ratio of 1.50 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.18. Likewise, its price to free cash flow for the trailing twelve months is 29.26.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 17.28, a number that is poised to hit 5.50 in the next quarter and is forecasted to reach 24.37 in one year’s time.
Technical Analysis of Thermo Fisher Scientific Inc (TMO)
Analysing the last 5-days average volume posted by the [Thermo Fisher Scientific Inc, TMO], we can find that recorded value of 5.16 million was better than the volume posted last year of 2.51 million. As of the previous 9 days, the stock’s Stochastic %D was 82.76%.
During the past 100 days, Thermo Fisher Scientific Inc’s (TMO) raw stochastic average was set at 61.60%, which indicates a significant decrease from 88.64% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 14.77 in the past 14 days, which was higher than the 13.13 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $414.00, while its 200-day Moving Average is $494.71. Now, the first resistance to watch is $483.15. This is followed by the second major resistance level at $487.97. The third major resistance level sits at $492.34. If the price goes on to break the first support level at $473.95, it is likely to go to the next support level at $469.58. Should the price break the second support level, the third support level stands at $464.76.
Thermo Fisher Scientific Inc (NYSE: TMO) Key Stats
Market capitalization of the company is 180.56 billion based on 377,494K outstanding shares. Right now, sales total 42,879 M and income totals 6,335 M. The company made 10,364 M in profit during its latest quarter, and 1,507 M in sales during its previous quarter.
